Cowden syndrome and the PTEN hamartoma tumor syndrome: How to define rare genetic syndromes

Journal of the National Cancer Institute

Volumn 105, Issue 21, 2013, Pages 1595-1597

  Lachlan, Katherine L ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

CLINICAL PRACTICE; COWDEN SYNDROME; EDITORIAL; GENE MUTATION; GENETIC SCREENING; HAMARTOMA; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PTEN HAMARTOMA TUMOR SYNDROME; SCORING SYSTEM;

GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; PTEN PHOSPHOHYDROLASE;

EID: 84890515064     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt290     Document Type: Editorial

References (21)

1. Lloyd KM II, Dennis M. Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med. 1963;58: 136-142.
2. Weary PE, Gorlin RJ, Gentry WC Jr, Comer JE, Gree KE. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol. 1972;106(5):682-690.
3. Starink TM, van der Veen JPW, Arwert F, et al. The Cowden syndrome: A clinical and genetic study in 21 patients. Clin Genet. 1986;29(3):222-233.
4. Gorlin RJ, Cohen, MM Jr, Condon, LM, Burke BA. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet. 1992;44(3):307-314.
5. Bannayan GA. Lipomatosis, angiomatosis,and macrencephalia. A previously undescribed congenital syndrome. Arch Pathol. 1971;92(1):1-5.
6. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16(1):64-67.
7. Marsh DJ, Dahia PL, Zheng Z, et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet. 1997;16(4):333-334.
8. Marsh DJ, Coulo, V, Lunetta KL, et al. Mutation spectrum and genotypephenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998;7(3):507-515.
9. Marsh DJ, Kum JB, Lunetta, KL, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999;8(3):1461-1472.
10. Merks JH, de Vries LS, et al. PTEN hamartoma tumour syndrome: variability of an entity. J Med Genet. 2003;40(10):e111.
11. Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet. 2007;449(11):579-585.
12. Ni Y, Zbuk KM, Sadler T, et al. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet. 2008;83(2):261-268.
13. Bayley JP. Succinate dehydrogenase gene variants and their role in Cowden syndrome. Am J Hum Genet. 2011;88(5):674-675.
14. Bennett KL, Mester J, Eng C. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA. 2010;304(24): 2724-2731.
15. Orloff MS, He X, Peterson C, et al. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes. Am J Hum Genet. 2013;92(1):76-80.
16. Mester J, Eng C. When overgrowth bumps into cancer: the PTENopathies. Am J Med Genet C Semin Med Genet. 2013;163(2):114-121.
17. Eng C. Cowden syndrome. J Genet Counsel. 1997;6(2):181-191.
18. Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet. 2000;37(11):828-830.
19. National Comprehensive Cancer Network. The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian Cancer. http://www.nccn.org. Accessed September 25, 2013.
20. Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105(21): 1607-1616.
21. Tan MH, Mester J, Peterson C, et al. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet. 2011;88(1):42-56.